Loading
Life sciences · Journal article
Journal of Agricultural and Food Chemistry · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Obesity and its associated insulin resistance are important risk factors for cognitive impairment. In this study, a 10-week C57BL/6 mouse model was established to investigate the effects of dietary quercetin supplementation at 0.05% (w/w) on HFFD-induced obesity-related cognitive impairment. The results showed that quercetin significantly reduced HFFD-induced body weight gain (P < 0.05) and improved serum lipid abnormalities and cognitive performance. Integrated multi-omics analysis further revealed that quercetin reshaped the gut microbiota composition, notably increasing Akkermansia muciniphila, restored intestinal barrier function, and regulated serum metabolite profiles. These alterations subsequently suppressed neuroinflammation, activated the hippocampal PI3K/AKT/GSK3β signaling pathway (with increases of 46%, 49%, and 50% in p-PI3K, p-Akt, and p-GSK-3β expression, respectively), and inhibited abnormal tau phosphorylation and neuronal apoptosis. The novelty of this study lies in constructing an integrated regulatory axis linking dietary quercetin, gut microbiota, serum metabolites, and hippocampal insulin signaling, providing novel mechanistic insights into quercetin in neuro-metabolic diseases.